1. Home
  2. XNCR vs CBNK Comparison

XNCR vs CBNK Comparison

Compare XNCR & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • CBNK
  • Stock Information
  • Founded
  • XNCR 1997
  • CBNK 1974
  • Country
  • XNCR United States
  • CBNK United States
  • Employees
  • XNCR N/A
  • CBNK N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • CBNK Major Banks
  • Sector
  • XNCR Health Care
  • CBNK Finance
  • Exchange
  • XNCR Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • XNCR 565.1M
  • CBNK 517.6M
  • IPO Year
  • XNCR 2013
  • CBNK 2018
  • Fundamental
  • Price
  • XNCR $8.44
  • CBNK $34.80
  • Analyst Decision
  • XNCR Buy
  • CBNK Hold
  • Analyst Count
  • XNCR 7
  • CBNK 1
  • Target Price
  • XNCR $27.50
  • CBNK $35.00
  • AVG Volume (30 Days)
  • XNCR 777.2K
  • CBNK 81.2K
  • Earning Date
  • XNCR 08-04-2025
  • CBNK 07-21-2025
  • Dividend Yield
  • XNCR N/A
  • CBNK 1.12%
  • EPS Growth
  • XNCR N/A
  • CBNK 6.54
  • EPS
  • XNCR N/A
  • CBNK 2.49
  • Revenue
  • XNCR $127,228,000.00
  • CBNK $188,910,000.00
  • Revenue This Year
  • XNCR N/A
  • CBNK $46.92
  • Revenue Next Year
  • XNCR $28.84
  • CBNK $7.82
  • P/E Ratio
  • XNCR N/A
  • CBNK $14.31
  • Revenue Growth
  • XNCR N/A
  • CBNK 20.92
  • 52 Week Low
  • XNCR $7.16
  • CBNK $21.77
  • 52 Week High
  • XNCR $27.24
  • CBNK $35.71
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 47.36
  • CBNK 65.16
  • Support Level
  • XNCR $7.93
  • CBNK $34.60
  • Resistance Level
  • XNCR $9.48
  • CBNK $35.70
  • Average True Range (ATR)
  • XNCR 0.53
  • CBNK 0.71
  • MACD
  • XNCR 0.06
  • CBNK 0.11
  • Stochastic Oscillator
  • XNCR 43.29
  • CBNK 90.59

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: